動画で説明:https://youtu.be/rTIPekfKyV4
MID:Minimally Important Difference
MCID:Minimum Clinically Important Difference
についての説明
追加:
文献4の中等度・著明改善の群分けは、以下にありました。また、1-7段階でなく、-7~7
という変ったGRCS ですね。
2.5. Data processing and statistical analysis
Subjects were classified as having no improvement when their responses to the GRCS were between -7 and 0, moderate improvement between 1 and 3 and large improvement between 4 and 7 after the treatment. Thus, the anchor-method approach was used to estimate the MCID of each of the outcome variables of interest (e.g. VAS, PPTs, HIT-6, CCFT) using the GRCS as the anchor.
動画で説明:https://youtu.be/rTIPekfKyV4
MID:Minimally Important Difference
MCID:Minimum Clinically Important Difference
についての説明
追加:
文献4の中等度・著明改善の群分けは、以下にありました。また、1-7段階でなく、-7~7
という変ったGRCS ですね。
2.5. Data processing and statistical analysis
Subjects were classified as having no improvement when their responses to the GRCS were between -7 and 0, moderate improvement between 1 and 3 and large improvement between 4 and 7 after the treatment. Thus, the anchor-method approach was used to estimate the MCID of each of the outcome variables of interest (e.g. VAS, PPTs, HIT-6, CCFT) using the GRCS as the anchor.